Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.
More and more, researchers, clinicians, and scientists are discovering that mitochondrial dysfunction correlates with metabolic syndromes such as diabetes, specifically type 2 diabetes. While combating obesity through diet and lifestyle ... Read more
Early detection of type 2 diabetes via expanded screenings in adults does not prevent deaths from cardiovascular disease but does slow the progression of diabetes, according to a new report. ... Read more
A new single-pill combination therapy developed by Boehringer Ingelheim and Eli Lilly to treat adults with type 2 diabetes received a positive opinion for approval by the Committee for Medicinal ... Read more
Rapidly urbanizing nations are experiencing an increased threat of diabetes-related tuberculosis (TB). According to a study, “Improving Tuberculosis Prevention and Care through Addressing the Global Diabetes Epidemic: From Evidence to ... Read more
A group at Wake Forest Baptist Medical Center recently used sophisticated metabolic measures and genetic analysis to probe the reason why people of Mexican ancestry are more likely to develop ... Read more
New therapeutic area standards for diabetes will make clinical research with diabetic patients more efficient and enhance diabetic treatments. The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma, Inc. ... Read more